Welcome to the BioPlus HCV advisory Committee. Here you will be
able to get answers about Hepatitis from some of the top researchers
across the country. You can also submit a question for response.
Answers to questions will be posted for others to read as well.
Questions will be submitted to the entire group and individual responses
will be posted.
Click here for Previously Asked Questions
Douglas
T. Dieterich, MD
Dr. Douglas T. Dieterich is a Professor of Medicine, Vice Chair,
and Chief Medical Officer of the Department of Medicine at Mount
Sinai School of Medicine, New York, New York. He has a triple appointment
in the divisions of Liver Disease, Gastroenterology, and Infectious
Diseases. Dr. Dieterich is an investigator for several ongoing studies
evaluating the safety and efficacy of various antiviral treatment
regimens for HIV and chronic hepatitis.
After graduating from Yale University, New Haven, Connecticut, Dr.
Dieterich received his medical degree from New York University School
of Medicine. He completed his internship and residency internal
medicine at the Bellevue Hospital Center in New York, where he was
also a fellow in the Division of Gastroenterology.
A fellow of both the American College of Physicians and the American
College of Gastroenterology, he is a member of many professional
societies. Dr. Dieterich has served on several committees of the
AIDS Clinical Trials Group, National Institutes of Health (NIH),
including the Steering Committee of the Opportunistic Infections
Core Committee and the Cytomegalovirus (CMV) Committee, and was
Chair and Co-chair, respectively, of the Enteric Parasites Committee
and Protozoan Committee. He also served on the NIH Study Sections
for CMV and cryptosporidiosis. Widely published, Dr. Dieterich is
the author of numerous journal articles, abstracts, and book chapters
on viral hepatitis and AIDS-associated infections of the gastrointestinal
tract and liver, and their treatment.
Robert
S. Brown, Jr., MD, MPH
Dr. Robert Brown is Associate Professor of Medicine &
Pediatrics and Chief of Clinical Hepatology, Columbia University
College of Physicians & Surgeons. In addition, he is also Medical
Director, Center for Liver Disease and Transplantation, New York
Presbyterian Hospital.
Dr. Brown is the author of numerous articles in the area of hepatology,
many of which deal with liver transplantation and the management
of viral hepatitis where he has extensive research funding from
the NIH and industry. Dr. Brown is a special section editor for
Hepatology, serves on the editorial board for Liver Transplantation
and as a reviewer for the journals Transplantation, American Journal
of Gastroenterology, New England Journal of Medicine, and the International
Journal of Epidemiology, among others.
He is a fellow in the American College of Physicians and the American
College of Gastroenterology, and a member of the American Gastroenterology
Association, American Association for the Study of Liver Diseases,
and American Society of Transplantation and American Society of
Transplant Surgeons. He received his MD degree (1989) from New York
University and his MPH from the Graduate School of Public Health
at the University of California at Berkeley. He completed a Fellowship
in Gastroenterology and Hepatology at the University of California,
San Francisco.
Cynthia M. Lachky PA-C
Cynthia Lachky PA-C began her career in GI and Hepatology in December
1999 upon enrolling in The Schering Corporation Fellowship Program
in Liver Disease for Physician Assistants. After the fellowship,
she remained employed by her mentor, Dr. Stephen P. Esposito, in
a large private practice in Queens, New York.
Ms. Lachky has participated in multiple Hepatitis C and GI clinical
trials as both a Sub-Investigator and the study coordinator.
Barry
Migicovsky, MD
Society Memberships:
American College of Gastroenterology
American Gastroenterology Association
American Society for Gastrointestinal Endoscopy
Florida Gastroenterology Society
Clinical Research:
A study for the Treatment of Patients with Interferon-Refractory
or Interferon-Relapsed Chronic Hepatitis C Intron A + Rebetol (Rivavirin).
Schering-Plough
Protocol R96-418
1997-1998
A study for the Treatment of Patients with Chronic Hepatitis C NOT
Previously Treated with Interferon-Intron A + Rebetol (Ribavirin).
Schering-Plough
Protocol R97-023
1997-1998
Multicenter Randomized Trial of 15 mcg Infergen (Interferon Alfacon-1)
Administered Daily vs Thrice Weekly in Patients with Chronic Hepatitis C Who Did Not Respond to Interferon Therapy.
Tse-Ling Fong, M.D.
Non-Responder Study
Protocol 980167
4/1999 – 7/2000
Induction Therapy Using 9 mcg Versus 15 mcg of Infergen Daily For
HCV Patients Who Have Failed Previous Interferon Therapy.
Paul Gaglio, M.D.
Non-Responder Study
Protocol 980181
4/1999 – 7/2000
Daily Induction Therapy with Infergen For HCV Patients Who Are Naive
to Interferon Therapy.
Paul J. Gaglio, M.D.
Naive Study
Protocol 980276
4/1999 – 7/2000
A Randomized, Open-Label, Multicenter, Efficacy, Tolerability and
Safety Study of Pegasys vs. Rebetron in Interferon and Ribavirin
Treatment Naive Patients with Chronic Hepatitis C Infection.
Roche Laboratories Inc.
Protocol N15952
10/5/1999-12/2001
Pegylated Interferon and Ribavirin for HCV Treatment Failure.
Schering-Plough
Paul J. Gaglio, M.D.
06/2000-Present
Comparison of PEG Interferon alfa-2b plus Ribavirin Given as a Fixed
Dose or on a Weight Optimized Basis for Treatment of Chronic Hepatitis
C in Previously Untreated Adult Subjects.
Schering-Plough
Ira Jacobson, M.D.
03/2001-Present
Phase II Study of Long Term Peg_Intron for Patients Who Have Failed
To Respond To Rebetron/Interferon With Advanced Fibrosis And Cirrhosis
Secondary To Hepatitis C.
Schering-Plough
Nezam H. Afdhal, M.D.
03/2002-Present
Natarajan Ravendhran, MD
Dr. Ravendhran practices Gastroenterology and Internal Medicine in Baltimore, Maryland. Dr. Natarajan Ravendhran graduated from the Stanley Med College Madras University with a MD and has been in the profession for 33 years.
Specialties:
- Gastroenterology
- Internal Medicine
Medical School Information
Medical School: Stanley Med College Madras University
Medical Degree: MD
Years Since Graduation: 33
Please Note: Due to volume considerations, not all questions can be answered. Questions most likely to be answered
will be those of general interest to a broad group of visitors to this forum. Questions pertaining to a specific case; requests for
diagnosis, medical advice, or second opinion; or requests for opinions about untested alternative therapies will generally not be answered.
Terms of Use: Please remember that this forum is designed for educational purposes only, and experts are not engaged
through this forum in rendering legal or medical advice or professional services. Experts appearing on this page are independent and
are solely responsible for editing and fact-checking their material. BioPlus Specialty Pharmacy Services, Inc. is not the publisher or
speaker of posted visitors' questions or the experts' material.
Questions and messages posted to this forum are not statements of advice, opinion, or information of BioPlus Specialty Pharmacy Services,
Inc. While BioPlus Specialty Pharmacy Services, Inc. does not regularly review posted content, we reserve the right to delete, move, or
edit postings if we deem it appropriate under the circumstances. Visitors submitting questions remain solely responsible for the content
of their messages.
Information provided by experts is general only and should not be used for diagnosing or treating a health problem or a disease, or relied
upon as legal or other professional advice. This information is not a substitute for professional advice or care. If you have or suspect
you may have a health or legal problem, you should consult your own health care provider or your attorney.